Treatment With α-1-Antitrypsin for Steroid-Refractory Acute Intestinal Graft-Versus- Host Disease: A Report of 2 Cases

被引：1
作者：
Gerner, Romana Raphaela [1 ]
Feistritzer, Clemens [2 ]
Moschen, Alexander Rupert [1 ]
Kircher, Brigitte [2 ]
Moser, Patrizia [3 ]
Tilg, Herbert [1 ]
Nachbaur, David [2 ]
机构：
[1] Med Univ Innsbruck, Univ Hosp Internal Med 1, Gastroenterol Endocrinol & Metab, Innsbruck, Austria
[2] Med Univ Innsbruck, Univ Hosp Internal Med 5, Hematol & Oncol, Innsbruck, Austria
[3] Med Univ Innsbruck, Dept Pathol, Innsbruck, Austria
来源：
TRANSPLANTATION | 2016年 / 100卷 / 12期
关键词：
MARROW-TRANSPLANTATION; FECAL CALPROTECTIN; GVHD;
D O I：
10.1097/TP.0000000000001470
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：E158 / E159
页数：2
相关论文
共 50 条
  • [31] Acute Steroid-Refractory Gastrointestinal Graft-Versus-Host Disease Is Not Associated With Significant Differences in Gut Taxonomic Composition Compared to Steroid-Sensitive Gastrointestinal Graft-Versus-Host Disease Immediately Before Onset of Disease
    Zeng, Ke
    Brewster, Ryan
    Kang, Joyce B.
    Tkachenko, Ekaterina
    Brooks, Erin
    Bhatt, Ami S.
    Fodor, Anthony A.
    Andermann, Tessa M.
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (02): : 237.e1 - 237.e9
  • [32] Vedolizumab plus basiliximab as second-line therapy for steroid-refractory lower gastrointestinal acute graft-versus-host disease
    Gao, Zicheng
    Fan, Zhiping
    Liu, Zhi
    Ye, Xu
    Zeng, Yunxin
    Xuan, Li
    Huang, Fen
    Lin, Ren
    Sun, Jing
    Liu, Qifa
    Xu, Na
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [33] A Prospective, Multicenter Study of Closed-System Extracorporeal Photopheresis for Children with Steroid-Refractory Acute Graft-versus-Host Disease
    Kitko, Carrie L.
    Abdel-Azim, Hisham
    Carpenter, Paul A.
    Dalle, Jean-Hugues
    Diaz-de-Heredia, Cristina
    Gaspari, Stefania
    Gennery, Andrew R.
    Handgretinger, Rupert
    Lawitschka, Anita
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (05): : 261.e1 - 261.e7
  • [34] Role of Ruxolitinib in Steroid-Refractory Graft versus Host Disease in Patients Undergoing Allogeneic Stem Cell Transplant
    Javed, Hammad
    Chaudhry, Qamarunnisa
    Shahbaz, Nighat
    Khan, Mehreen Ali
    Iftikhar, Raheel
    Yousaf, Muhammad
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (09): : 1225 - 1227
  • [35] Anti-Apoptotic Molecule BCL2 Is a Therapeutic Target in Steroid-Refractory Graft-Versus-Host Disease
    Strobl, Johanna
    Pandey, Ram Vinay
    Krausgruber, Thomas
    Kleissl, Lisa
    Reininger, Baerbel
    Herac, Merima
    Bayer, Nadine
    Krall, Christoph
    Wohlfarth, Philipp
    Mitterbauer, Margit
    Kalhs, Peter
    Rabitsch, Werner
    Bock, Christoph
    Hopfinger, Georg
    Stary, Georg
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (11) : 2188 - 2198
  • [36] Surgery for intestinal graft-versus-host disease - Report of two cases
    Evans, J
    Percy, J
    Eckstein, R
    Schnitzler, M
    DISEASES OF THE COLON & RECTUM, 1998, 41 (12) : 1573 - 1576
  • [37] Ruxolitinib in children with steroid-refractory acute graft-versus-host disease: A retrospective multicenter study of the pediatric group of SFGM-TC
    Laisne, Louise
    Neven, Benedicte
    Dalle, Jean-Hugues
    Galambrun, Claire
    Esvan, Maxime
    Renard, Cecile
    Rialland, Fanny
    Sirvent, Anne
    Gandemer, Virginie
    PEDIATRIC BLOOD & CANCER, 2020, 67 (09)
  • [38] Mycophenolate mofetil is effective only for involved skin in the treatment for steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Hattori, Kenichiro
    Doki, Noriko
    Kurosawa, Shuhei
    Hino, Yutaro
    Yamamoto, Keita
    Sakaguchi, Masahiro
    Harada, Kaito
    Ikegawa, Shuntaro
    Shingai, Naoki
    Senoo, Yasushi
    Igarashi, Aiko
    Najima, Yuho
    Kobayashi, Takeshi
    Kakihana, Kazuhiko
    Sakamaki, Hisashi
    Ohashi, Kazuteru
    ANNALS OF HEMATOLOGY, 2017, 96 (02) : 319 - 321
  • [39] Ruxolitinib in steroid-refractory acute graft-vs-host disease: Japanese subgroup analysis of the randomized REACH2 trial
    Teshima, Takanori
    Onishi, Yasushi
    Kato, Koji
    Taniguchi, Shuichi
    Miyamura, Koichi
    Fukushima, Kentaro
    Kato, Jun
    Ishikawa, Takayuki
    Doki, Noriko
    Nakamae, Hirohisa
    Maeda, Yoshinobu
    Inamoto, Yoshihiro
    Okada, Masaya
    Maki, Akio
    Shimada, Fumika
    Tajima, Takeshi
    Wroclawska, Monika
    Zeiser, Robert
    Onizuka, Makoto
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 120 (01) : 106 - 116
  • [40] Phase 1 multicenter trial of brentuximab vedotin for steroid- refractory acute graft-versus-host disease
    Chen, Yi-Bin
    Perales, Miguel-Angel
    Li, Shuli
    Kempner, Maria
    Reynolds, Carol
    Brown, Jami
    Efebera, Yvonne A.
    Devine, Steven M.
    El-Jawahri, Areej
    McAfee, Steven L.
    Spitzer, Thomas R.
    Soiffer, Robert J.
    Ritz, Jerome
    Cutler, Corey
    BLOOD, 2017, 129 (24) : 3256 - 3261
12345